11 Best Medical Stocks to Buy According to Analysts

Page 8 of 11

4. Zoetis Inc. (NYSE:ZTS)

Analyst Upside: 37.18%

Number of Hedge Fund Holders: 74

Zoetis Inc. (NYSE:ZTS) ranks among the best medical stocks to buy according to analysts. With a price target of $210, Piper Sandler reaffirmed its Overweight rating on Zoetis Inc. (NYSE:ZTS) on July 2. According to the firm’s analysis, Zoetis’ 2025 guidance is unlikely to be negatively impacted by rising competition in its two largest franchises, dermatology and broad-spectrum parasiticides.

According to Piper Sandler, although Elanco’s Credelio Quattro launch was successful, the new product has largely contributed to market expansion rather than capturing a sizable portion of Zoetis’ market.

Based on the strength of its key businesses, Piper Sandler believes Zoetis Inc. (NYSE:ZTS) might still surpass revenue projections even if Librela, one of its products, may experience softness.

Global animal health provider Zoetis Inc. (NYSE:ZTS) focuses on delivering high-quality medications, vaccines, diagnostic tools, genetic testing, and services.

Page 8 of 11